{"id":"W2384957276","doi":"","title":"Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study","year":2005,"lang":"en","type":"article","venue":"Dkgest of the World Latest Medical Information","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Expanded Disability Status Scale; Interferon beta-1b; Multiple sclerosis; Placebo; Internal medicine; Clinical endpoint; Interferon beta-1a; Randomized controlled trial; Clinical trial; Magnetic resonance imaging; Physical therapy; Surgery; Interferon beta; Pathology; Immunology; Radiology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006065066,0.001049353,0.004276159,0.0003880698,0.0006952042,0.001012983,0.0007824696,0.001721212,0.002711582],"category_scores_gemma":[0.00236884,0.0003589128,0.00294125,0.0007095186,0.0008770048,0.0005764354,0.0002705189,0.00195483,0.0004745674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007556201,"about_ca_system_score_gemma":0.00138607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001631425,"about_ca_topic_score_gemma":0.002050881,"domain_scores_codex":[0.9981574,0.0008351636,0.000227078,0.0002747854,0.0002743058,0.000231319],"domain_scores_gemma":[0.9978769,0.0005488489,0.0005556592,0.0001892031,0.0003271965,0.0005022244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9089917,0.01503371,0.005808039,0.002371438,0.00384348,0.0002190136,0.0001699122,0.0002858334,0.01068226,0.00006221329,0.001377446,0.05115502],"study_design_scores_gemma":[0.7695916,0.1841937,0.03906047,0.0002266077,0.003099646,0.0002371621,0.0000391099,0.0003109293,0.001199623,0.00005844684,0.001952084,0.00003070167],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624963,0.03112599,0.0009625627,0.0004067201,0.0004191544,0.002235407,0.001041722,0.0001064087,0.001205813],"genre_scores_gemma":[0.9812474,0.01114372,0.001008761,0.001110296,0.0006397318,0.001978349,0.001755132,0.00002391338,0.0010928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006065066,"threshold_uncertainty_score":0.03207552,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02127426181270518,"score_gpt":0.31310377270854,"score_spread":0.2918295108958348,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}